Paragangliomas: etiology, presentation, and management.

Area of Science:

• Endocrinology
• Oncology
• Genetics

Background:

• Paragangliomas are catecholamine-secreting tumors originating from sympathetic ganglia, also known as extra-adrenal pheochromocytomas.
• These tumors can manifest as episodic hypertension, tachycardia, headache, and diaphoresis, and may be benign or malignant.

Purpose of the Study:

• To provide a comprehensive overview of paraganglioma diagnosis, management, and genetic associations.
• To highlight the importance of genetic testing in specific patient populations and the need for long-term follow-up.

Main Methods:

• Diagnosis involves serum and urine analysis for catecholamines and metanephrines.
• Imaging studies such as CT, MRI, and 123-I MIBG scintigraphy confirm diagnosis.
• Genetic testing is recommended for young patients, those with multiple tumors, or a family history of malignancy.

Main Results:

• The majority of paragangliomas are sporadic, but a significant percentage are linked to familial genetic syndromes.
• Surgical resection is the primary treatment, requiring careful perioperative alpha- and beta-adrenergic blockade.
• Chemotherapy and radiation may offer modest benefits for malignant cases, with a high recurrence rate necessitating long-term surveillance.

Conclusions:

• Paraganglioma management requires a multidisciplinary approach, emphasizing accurate diagnosis, surgical intervention, and vigilant follow-up.
• Understanding the genetic basis of paraganglioma is crucial for personalized treatment and the development of targeted therapies.